(RYTM) –
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $52 at Wells Fargo
-
Form SC 13D/A RHYTHM PHARMACEUTICALS, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 4 RHYTHM PHARMACEUTICALS, For: Apr 14 Filed by: Mazabraud Yann
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
-
Form 8-K RHYTHM PHARMACEUTICALS, For: Apr 15
-
M&A watch: 3 biotech companies that are most likely to be acquired - Needham
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 20 Filed by: German Christopher Paul
-
Form SC 13D/A RHYTHM PHARMACEUTICALS, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 8-K RHYTHM PHARMACEUTICALS, For: Apr 01
-
Rhythm Pharmaceuticals (RYTM) Secures $150M in Convertible Preferred Stock Financing
-
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
-
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 21 Filed by: Shulman Joseph
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 20 Filed by: Lee Jennifer Kayden
-
Form 144 RHYTHM PHARMACEUTICALS, Filed by: Shulman Joseph
-
Form SC 13D RHYTHM PHARMACEUTICALS, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 144 RHYTHM PHARMACEUTICALS, Filed by: Lee Jennifer Kayden
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 19 Filed by: Smith Hunter C
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 19 Filed by: Shulman Joseph
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 19 Filed by: Meeker David P
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 19 Filed by: Mazabraud Yann
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 19 Filed by: Lee Jennifer Kayden
-
Form 4 RHYTHM PHARMACEUTICALS, For: Mar 19 Filed by: Cramer Pamela J.
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
-
Form S-8 RHYTHM PHARMACEUTICALS,
-
Form 8-K RHYTHM PHARMACEUTICALS, For: Feb 29
-
Form 424B5 RHYTHM PHARMACEUTICALS,
-
Form 10-K RHYTHM PHARMACEUTICALS, For: Dec 31
-
Rhythm Pharmaceuticals (RYTM) Reports In-Line Q4 EPS, provides guidance
-
Rhythm Pharmaceuticals (RYTM) Announces Clinical Development Plan of Setmelanotide
-
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan
-
Form 8-K RHYTHM PHARMACEUTICALS, For: Feb 22
-
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial ResultsĀ and Business Update
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 16 Filed by: Meeker David P
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 16 Filed by: Mazabraud Yann
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 16 Filed by: German Christopher Paul
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 16 Filed by: Cramer Pamela J.
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 16 Filed by: Smith Hunter C
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 16 Filed by: Lee Jennifer Kayden
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 16 Filed by: Shulman Joseph
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 13 Filed by: Shulman Joseph
-
Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A RHYTHM PHARMACEUTICALS, Filed by: BAKER BROS. ADVISORS LP
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 09 Filed by: Smith Hunter C
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 09 Filed by: Mazabraud Yann
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 09 Filed by: Lee Jennifer Kayden
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 09 Filed by: Shulman Joseph
-
Form 4 RHYTHM PHARMACEUTICALS, For: Feb 09 Filed by: Cramer Pamela J.
-
Form SC 13G RHYTHM PHARMACEUTICALS, Filed by: VANGUARD GROUP INC
Back to RYTM Stock Lookup